Hongbin Liu

Person

Chongqing, CN

People

Patents Grantslast 30 patents

Information Patent Grant
Macrocyclic compounds as TRK kinases inhibitors
- Patent number 11,555,042
- Issue date Jan 17, 2023
- Fochon Biosciences, Ltd.
- Huajie Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted 2-azabicyclo[3.1.0]hexanes as TRK kinases inhibitors
- Patent number 11,459,332
- Issue date Oct 4, 2022
- Fochon Biosciences, Ltd.
- Hongbin Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Sulfoximine, sulfonimidamide, sulfondiimine and diimidosulfonamide...
- Patent number 11,168,078
- Issue date Nov 9, 2021
- Shanghai Fochon Pharmaceutical Co., LTD
- Zhifang Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Apoptosis-inducing agents
- Patent number 11,091,478
- Issue date Aug 17, 2021
- Fochon Pharmaceutical Co., Ltd.
- Hongbin Liu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds as BLC-2-selective apoptosis-inducing agents
- Patent number 11,053,239
- Issue date Jul 6, 2021
- Fochon Pharmaceuticals, Ltd.
- Xingdong Zhao
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Certain protein kinase inhibitors
- Patent number 9,567,342
- Issue date Feb 14, 2017
- Shanghai Fochon Pharmaceutical Co., LTD
- Weibo Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Certain protein kinase inhibitors
- Patent number 9,206,166
- Issue date Dec 8, 2015
- Shanghai Institute of Materia Medica Academy of Sciences
- Weibo Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
APOPTOSIS-INDUCING AGENTS
- Publication number 20220402913
- Publication date Dec 22, 2022
- Fochon Pharmaceutical, Ltd.
- Hongbin LIU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MACROCYCLIC COMPOUNDS AS TRK KINASES INHIBITORS
- Publication number 20210139506
- Publication date May 13, 2021
- FOCHON PHARMACEUTICALS, LTD.
- Huajie ZHANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SULFOXIMINE, SULFONIMIDAMIDE, SULFONDIIMINE AND DIIMIDOSULFONAMIDE...
- Publication number 20210070742
- Publication date Mar 11, 2021
- SHANGHAI FOCHON PHARMACEUTICAL CO., LTD.
- Zhifang CHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED (2-AZABICYCLO[3.1.0]HEXAN-2-YL)PYRAZOLO[1,5-a]PYRIMIDIN...
- Publication number 20210024528
- Publication date Jan 28, 2021
- Fochon Pharmaceuticals Ltd.
- Hongbin LIU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
APOPTOSIS-INDUCING AGENTS
- Publication number 20200115379
- Publication date Apr 16, 2020
- SHANGHAI FOCHON PHARMACEUTICAL CO., LTD.
- Hongbin LIU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AS BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS
- Publication number 20190345156
- Publication date Nov 14, 2019
- SHANGHAI FOCHON PHARMACEUTICAL CO., LTD.
- Xingdong ZHAO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CERTAIN PROTEIN KINASE INHIBITORS
- Publication number 20160046638
- Publication date Feb 18, 2016
- SHANGHAI FOCHON PHARMACEUTICAL CO., LTD.
- Weibo WANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CERTAIN PROTEIN KINASE INHIBITORS
- Publication number 20140128387
- Publication date May 8, 2014
- SHANGHAI iNSTITUTE OF MATERIA MEDICA ACADEMY OF SCIENCES
- Weibo WANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Hongbin Liu

Person

Patents Grantslast 30 patents

Macrocyclic compounds as TRK kinases inhibitors

Substituted 2-azabicyclo[3.1.0]hexanes as TRK kinases inhibitors

Sulfoximine, sulfonimidamide, sulfondiimine and diimidosulfonamide...

Apoptosis-inducing agents

Compounds as BLC-2-selective apoptosis-inducing agents

Certain protein kinase inhibitors

Certain protein kinase inhibitors

Patents Applicationslast 30 patents

APOPTOSIS-INDUCING AGENTS

MACROCYCLIC COMPOUNDS AS TRK KINASES INHIBITORS

SULFOXIMINE, SULFONIMIDAMIDE, SULFONDIIMINE AND DIIMIDOSULFONAMIDE...

SUBSTITUTED (2-AZABICYCLO[3.1.0]HEXAN-2-YL)PYRAZOLO[1,5-a]PYRIMIDIN...

APOPTOSIS-INDUCING AGENTS

COMPOUNDS AS BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS

CERTAIN PROTEIN KINASE INHIBITORS

CERTAIN PROTEIN KINASE INHIBITORS